SCHEMBL26320533

SCHEMBL26320533

Cc1ccc(C(=O)CS(=O)(=O)c2nc(-c3ccccc3)cs2)cc1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.43
USP2 O75604 1/20 0.42
PKM P14618 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
PHGDH O43175 4/20 0.41
BLM P54132 1/20 0.41
RAB9A P51151 3/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HSD11B1 P28845 1/20 0.39
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23196652 0.90 MAPT (0.45) MAPTMEN1KMT2AALDH1A1USP2
SCHEMBL26320536 0.78 ALPL (0.47) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL26320499 0.77 RAB9A (0.56) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL26320532 0.75 RAB9A (0.40) MAPTMEN1KMT2APHGDHBLM
SCHEMBL18997366 0.69 MAPT (0.43) MAPTMEN1KMT2AALDH1A1USP2
SCHEMBL26320526 0.68 ALDH1A1 (0.43) MAPTMEN1KMT2AALDH1A1HSD11B1
SCHEMBL11705681 0.67 ALDH1A1 (0.52) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL9093997 0.67 ALDH1A1 (0.56) MAPTMEN1KMT2AALDH1A1MAPK1
SCHEMBL23196653 0.67 ALPL (0.59) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL23196643 0.66 ALPG (0.61) MAPTMEN1KMT2AALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230293499-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO US GOV VETERANS AFFAIRS (US) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293499-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO NFKBIA, NCBP1, NFKB1 MAPT 3493/4885MEN1 3170/4885KMT2A 2991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.